These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 17453722)

  • 1. Multiple specificities of autoantibodies against hnRNP A/B proteins in systemic rheumatic diseases and hnRNP L as an associated novel autoantigen.
    Siapka S; Patrinou-Georgoula M; Vlachoyiannopoulos PG; Guialis A
    Autoimmunity; 2007 May; 40(3):223-33. PubMed ID: 17453722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
    J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to heterogeneous nuclear ribonucleoproteins.
    Caporali R; Bugatti S; Bruschi E; Cavagna L; Montecucco C
    Autoimmunity; 2005 Feb; 38(1):25-32. PubMed ID: 15804702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases.
    Steiner G; Skriner K; Smolen JS
    Int Arch Allergy Immunol; 1996 Dec; 111(4):314-9. PubMed ID: 8957102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease.
    Schett G; Dumortier H; Hoefler E; Muller S; Steiner G
    Ann Rheum Dis; 2009 May; 68(5):729-35. PubMed ID: 18495733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome.
    Zimmermann C; Steiner G; Skriner K; Hassfeld W; Petera P; Smolen JS
    Arthritis Rheum; 1998 Nov; 41(11):1938-45. PubMed ID: 9811047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoantibodies to the heterogeneous nuclear ribonucleoproteins and the autoimmune diseases].
    Yang L; Yu M; Yang C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Aug; 21(4):311-4. PubMed ID: 12567457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
    Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
    Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis.
    Montecucco C; Caporali R; Cobianchi F; Biamonti G
    Arthritis Rheum; 1996 Oct; 39(10):1669-76. PubMed ID: 8843857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on autoantibodies to intracellular antigens in systemic rheumatic diseases.
    Nakamura RM; Tan EM
    Clin Lab Med; 1992 Mar; 12(1):1-23. PubMed ID: 1563236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against heterogeneous nuclear ribonucleoprotein B1 in CSF of MS patients.
    Sueoka E; Yukitake M; Iwanaga K; Sueoka N; Aihara T; Kuroda Y
    Ann Neurol; 2004 Dec; 56(6):778-86. PubMed ID: 15497154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus.
    Hassfeld W; Steiner G; Studnicka-Benke A; Skriner K; Graninger W; Fischer I; Smolen JS
    Arthritis Rheum; 1995 Jun; 38(6):777-85. PubMed ID: 7779120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantification of SS-B autoantibodies in patient sera using highly purified human SS-B antigens and their clinical interpretation].
    Pfeifle J; Wolff JM; Anderer FA; Franke M
    Z Rheumatol; 1986; 45(6):296-303. PubMed ID: 3493602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases.
    Op De Beéck K; Maes L; Van den Bergh K; Derua R; Waelkens E; Van Steen K; Vermeersch P; Westhovens R; De Vlam K; Verschueren P; Hooijkaas H; Blockmans D; Bossuyt X
    Arthritis Rheum; 2012 Jan; 64(1):213-21. PubMed ID: 21905010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hnRNP B1 (RA33) autoantibodies are associated with the clinical phenotype in Russian patients with rheumatoid arthritis and systemic sclerosis.
    Maslyanskiy A; Lazareva N; Olinek P; Schierack P; Hentschel C; Cuccato J; Bogdanos DP; Lapin SV; Roggenbuck D
    J Immunol Res; 2014; 2014():516593. PubMed ID: 24883333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and immunological aspects of autoantibodies to RA33/hnRNP-A/B proteins--a link between RA, SLE and MCTD.
    Steiner G; Skriner K; Hassfeld W; Smolen JS
    Mol Biol Rep; 1996; 23(3-4):167-71. PubMed ID: 9112225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex.
    Steiner G; Hartmuth K; Skriner K; Maurer-Fogy I; Sinski A; Thalmann E; Hassfeld W; Barta A; Smolen JS
    J Clin Invest; 1992 Sep; 90(3):1061-6. PubMed ID: 1522214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients assist in autoantibody production.
    Greidinger EL; Gazitt T; Jaimes KF; Hoffman RW
    Arthritis Rheum; 2004 Jul; 50(7):2216-22. PubMed ID: 15248220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum and clinical significance of autoantibodies against transfer RNA.
    Ohosone Y; Ishida M; Takahashi Y; Matsumura M; Hirakata M; Kawahara Y; Nishikawa T; Mimori T
    Arthritis Rheum; 1998 Sep; 41(9):1625-31. PubMed ID: 9751095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.